Mitarbeiter: 11 (2023.0)Rechtsform: SCA (commandite par actions)Größe: PMEGründungsdatum: 1985-04-01 (41 Jahre)Status: AktivBranche: Fabrication de préparations pharmaceutiquesStandort: REIMS (51100), Marne
INSTITUT DE BIOTECHNOLOGIES JACQUES BOY : revenue, balance sheet and financial ratios
INSTITUT DE BIOTECHNOLOGIES JACQUES BOY is a French company
founded 41 years ago,
specialized in the sector Fabrication de préparations pharmaceutiques.
Based in REIMS (51100),
this company of category PME
shows in 2017 a revenue of 1.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Le compte de résultat détaillé n'est pas disponible pour cette entreprise (liasse simplifiée ou données confidentielles).
Évolution graphique
Anzeigen :
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Aktiva
Chargement des données...
Poste
Brutto
Abschr.
Netto
%
Entwicklung
Données de bilan actif non disponibles pour cette entreprise
Passiva
Chargement des données...
Poste
Jahr
%
Entwicklung
Données de bilan passif non disponibles pour cette entreprise
Solvenz- und Verschuldungskennzahlen
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 76%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Verschuldungsgrad (2024)
?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible 50-100% : Moderat > 100% : Hoch
0.134%
Finanzielle Autonomie (2024)
?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Entwicklung der Solvenzkennzahlen INSTITUT DE BIOTECHNOLOGIES JACQUES BOY
Visualisierung erstellt mit numbers.finance Sources : INPI & BCE - Anpassungen : Ministère de l'Économie
Kennzahl
2016
2017
2018
2019
2020
2022
2023
2024
Verschuldungsgrad
-159.314
-192.876
155.014
92.117
44.646
3.585
1.745
0.134
Finanzielle Autonomie
-40.265
-36.59
26.841
34.654
45.28
76.548
83.538
76.268
Rückzahlungsfähigkeit
-1.801
4.208
None
None
None
None
None
None
Cashflow / Umsatz
-26.326%
10.6%
None%
None%
None%
None%
None%
None%
Positionnement sectoriel
Debt ratio
0.132024
2022
2023
2024
Q1: 0.0
Méd: 5.92
Q3: 43.75
Good-19 pts über 3 Jahre
In 2024, the debt ratio of INSTITUT DE BIOTECHNOLOGI... (0.13) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
76.27%2024
2022
2023
2024
Q1: 28.05%
Méd: 51.52%
Q3: 72.2%
Excellent
In 2024, the financial autonomy of INSTITUT DE BIOTECHNOLOGI... (76.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquiditätskennzahlen
The liquidity ratio (= Current assets / Current liabilities) stands at 332.52. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquiditätsquote (2024)
?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut 1-1.5 : Angemessen < 1 : Risque de liquidité
332.524
Entwicklung der Liquiditätskennzahlen INSTITUT DE BIOTECHNOLOGIES JACQUES BOY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Kennzahl
2016
2017
2018
2019
2020
2022
2023
2024
Liquiditätsquote
123.29
141.834
266.82
258.427
215.624
379.148
513.574
332.524
Zinsdeckung
-3.208
9.64
None
None
None
None
None
None
Positionnement sectoriel
Liquidity ratio
332.522024
2022
2023
2024
Q1: 120.09
Méd: 209.86
Q3: 363.93
Good-5 pts über 3 Jahre
In 2024, the liquidity ratio of INSTITUT DE BIOTECHNOLOGI... (332.52) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Umlaufvermögensbedarf und Zahlungsfristen
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operatives Working Capital (2024)
?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Frequently asked questions about INSTITUT DE BIOTECHNOLOGIES JACQUES BOY
What is the revenue of INSTITUT DE BIOTECHNOLOGIES JACQUES BOY ?
The revenue of INSTITUT DE BIOTECHNOLOGIES JACQUES BOY in 2017 is 1.7 M€.
Is INSTITUT DE BIOTECHNOLOGIES JACQUES BOY profitable?
INSTITUT DE BIOTECHNOLOGIES JACQUES BOY recorded a net loss in 2024.
Where is the headquarters of INSTITUT DE BIOTECHNOLOGIES JACQUES BOY ?
The headquarters of INSTITUT DE BIOTECHNOLOGIES JACQUES BOY is located in REIMS (51100), in the department Marne.
Where to find the tax return of INSTITUT DE BIOTECHNOLOGIES JACQUES BOY ?
The tax return of INSTITUT DE BIOTECHNOLOGIES JACQUES BOY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does INSTITUT DE BIOTECHNOLOGIES JACQUES BOY operate?
INSTITUT DE BIOTECHNOLOGIES JACQUES BOY operates in the sector Fabrication de préparations pharmaceutiques (NAF code 21.20Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Drehen Sie Ihr Telefon ins Querformat, um das Diagramm anzuzeigen